Goldman Sachs’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $80.1K | Sell |
|
|||||
|
2025
Q2 | $308K | Sell |
|
|||||
|
2025
Q1 | $164K | Sell |
|
|||||
|
2024
Q4 | $399K | Buy |
|
|||||
|
2024
Q3 | $630K | Buy |
|
|||||
|
2024
Q2 | $627K | Buy |
|
|||||
|
2024
Q1 | $375K | Sell |
|
|||||
|
2023
Q4 | $360K | Sell |
|
|||||
|
2023
Q3 | $392K | Sell |
|
|||||
|
2023
Q2 | $1.27M | Buy |
|
|||||
|
2023
Q1 | $702K | Buy |
|
|||||
|
2022
Q4 | $509K | Buy |
|
|||||
|
2022
Q3 | $578K | Buy |
|
|||||
|
2022
Q2 | $387K | Buy |
|
|||||
|
2022
Q1 | $381K | Buy |
|
|||||
|
2021
Q4 | $621K | Buy |
|
|||||
|
2021
Q3 | $432K | Buy |
|
|||||
|
2021
Q2 | $326K | Buy |
|
|||||
|
2021
Q1 | $382K | Sell |
|
|||||
|
2020
Q4 | $250K | Sell |
|
|||||
|
2020
Q3 | $203K | Sell |
|
|||||
|
2020
Q2 | $1.03M | Buy |
|
|||||
|
2020
Q1 | $392K | Buy |
|
|||||
|
2019
Q4 | $599K | Sell |
|
|||||
|
2019
Q3 | $554K | Buy |
|
|||||
|
2019
Q2 | $738K | Buy |
|
|||||
|
2019
Q1 | $644K | Buy |
|
|||||
|
2018
Q4 | $698K | Sell |
|
|||||
|
2018
Q3 | $1.17M | Sell |
|
|||||
|
2018
Q2 | $1.39M | Buy |
|
|||||
|
2018
Q1 | $578K | Sell |
|
|||||
|
2017
Q4 | $1.33M | Sell |
|
|||||
|
2017
Q3 | $3M | Buy |
|
|||||
|
2017
Q2 | $2.21M | Buy |
|
|||||
|
2017
Q1 | $1.63M | Sell |
|
|||||
|
2016
Q4 | $2.35M | Buy |
|
|||||
|
2016
Q3 | $2.23M | Buy |
|
|||||
|
2016
Q2 | $1.19M | Sell |
|
|||||
|
2016
Q1 | $2.25M | Buy |
|
|||||
|
2015
Q4 | $1.5M | Sell |
|
|||||
|
2015
Q3 | $5.73M | Buy |
|
|||||
|
2015
Q2 | $173K | Sell |
|
|||||
|
2015
Q1 | $182K | Sell |
|
|||||
|
2014
Q4 | $316K | Buy |
|
|||||
|
2014
Q3 | $121K | Buy |
|
|||||
|
2014
Q2 | $136K | Buy |
|
|||||
|
2014
Q1 | $124K | Sell |
|
|||||
|
2013
Q4 | $395K | Sell |
|
|||||
|
2013
Q3 | $637K | Buy |
|
|||||
|
2013
Q2 | $183K | Buy |
|